Greece: Infringement by equivalence affirmed

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Greece: Infringement by equivalence affirmed

While the doctrine of equivalents exists in theory in most Greek legal textbooks, judgments applying this theory in practice are scarce in Greece. A recently issued judgment by the Athens Court of First Instance in preliminary injunction proceedings is an important addition to this rather small number of judgments.

The dispute at issue arose when a foreign pharmaceutical company filed a preliminary injunction application against a Greek pharmaceutical company, which manufactured a pharmaceutical solution for export abroad, claiming infringement of its patented manufacturing process.

The defendant argued that its manufacturing process was different highlighting, inter alia, a difference in the order of the steps performed for the preparation of its pharmaceutical solution compared to the patented process.

The Court was not convinced by the defendant's line of defence. After providing an analysis of the doctrine of equivalents theory, the judgment found that both processes employ the same material and that the steps performed are the same. The judge added that the main features of the invention were present in both processes and that the change in the order of the process steps by the defendant had no significance for the final result.

A preliminary injunction was thus granted ordering the defendant to cease any productive activity infringing the patent, to recall the manufactured products and to provide the claimant with all information necessary to identify any parties involved in the distribution and marketing of the infringing products abroad. Furthermore the Court ordered the provisional seizure of any infringing products found in the possession of the defendant or any other party deriving rights therefrom.

A further interesting aspect of this judgment is that the products were not manufactured to be sold in Greece but were only intended to be exported for sale in foreign markets. The grant of a preliminary injunction against the manufacturer may therefore constitute an effective strategy in preventing those sales in a larger number of countries.

kilimiris.jpg

Constantinos Kilimiris


Patrinos & Kilimiris7, Hatziyianni Mexi Str.GR-11528 AthensGreeceTel: +30210 7222906, 7222050Fax: +30210 7222889info@patrinoskilimiris.comwww.patrinoskilimiris.com

more from across site and SHARED ros bottom lb

More from across our site

Monetisation is standing at the forefront of patent development, and one firm says AI is increasingly being deployed
Data centres are being built across the US, prompting patent disputes, but Texas’s thriving tech industry and patent-ready courts make the state particularly ‘ripe’ for litigation
Carpmaels & Ransford is set to bolster its UK attorney team with the appointment of Simmons & Simmons’s head of IP in the UK
Updates on Nokia’s licensing strides and a surge in patent activity around battery recycling in Australia were also among the top talking points
To mark International Day Against Child Labour, Matteo Amerio at Corsearch says the people inside businesses who can identify counterfeiting risks must be given the tools and authority to act
With genuine equity at IP firms becoming rarer, securing partnership is harder than ever, but increased transparency is also making climbing the ladder more predictable
Yossi Sivan explains how Israeli judgment is a pro-brand owner departure from the norm and why it sends a strong message that corporate structures are not always a shield
Halim Shehadeh, group CEO of IP firm CWB, says that in the rush to discuss what AI can do, IP firms are overlooking the more important question of whether they are ready
Caitlin Heard, who formally joined the firm from CMS last month, says she is excited by the ‘energy’ of the London office
Ranjna Mehta-Dutt, who moved to Chadha & Chadha after 25 years at Remfry & Sagar, says the firm plans to expand its life sciences practice through targeted recruitment and dedicated teams for bigger clients
Gift this article